If human trials with the compound show safety and efficacy, NNMT inhibitors like 5-amino-1MQ could serve to prevent and/or slow age-related muscle deterioration in humans, a tantalizing prospect
The FDA approved semaglutide for type 2 diabetes and weight loss in people with obesity or overweight with at least one weight-related health condition
Both were removed from FDA 503A Category 2 on April 22, 2026, but neither is on Category 1 either
Verdict: Go Highest margins and clearest "Job-to-be-Done" (acute injury recovery)
Better Performance A leaner body means less work your heart has to do to get blood, oxygen, and nutrients where theyre needed
Combination Protocols: AOD-9604 can be combined with other metabolic support peptides or compounds, though careful consideration should be given to potential interactions